Share Price
32.00 p
0 (0.00 %)
Market Cap
£14.97 m
Proactive Investors - Run By Investors For Investors


IXICO’s TrialTracker® platform and Artificial Intelligence (AI) software algorithms are used by the global pharmaceutical industry to collate and interpret brain scan data from MRI and positron emission tomography (PET) scanners, as well as to make sense of real-world data collected using wearable biosensors.  Our specialist data analytics services identify and measure unique biomarkers...

Market: AIM:IXI
52-week High/Low: 43.00p / 18.78p
Sector: Pharma & Biotech
Market Cap: £14.97 m
Website: www.ixico.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of IXICO PLC

IXICO PLC Timeline

The neuroscience-focused data analytics group reported a pre-tax profit on ordinary activities of £106,000, up from a £514,000 loss in the prior year
IXICO's data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable better trial design, site qualification, patient selection and clinical outcomes

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use